Valion Bio (VBIO) Change in Inventory (2021 - 2025)
Valion Bio (VBIO) posted quarterly Change in Inventory of -$16.2 million for Q4 2025, down 179744.44% year-over-year from N/an in Q4 2024, and down 32895.92% quarter-over-quarter from -$49000.0 in Q3 2025.
Valion Bio (VBIO) Change in Inventory (2021 - 2025) Analysis & Trends
Valion Bio's Change in Inventory history runs 5 years deep, the most recent figure standing at -$16.2 million for Q4 2025.
- In Q4 2025, Change in Inventory fell 179744.44% year-over-year to -$16.2 million; the TTM figure through Dec 2025 stood at -$16.3 million (changed N/A YoY), while the FY2025 annual figure was -$16.3 million, changed N/A from the prior year.
- Change in Inventory for Q4 2025 stood at -$16.2 million, down from -$49000.0 in the prior quarter.
- The five-year high for Change in Inventory was $386000.0 in Q2 2022, with the low at -$16.2 million in Q4 2025.
- The 5-year median for Change in Inventory is $9000.0 (2024), against an average of -$827000.0.
- The sharpest annual moves came in 2022 and 2025: Change in Inventory soared 687.76% in 2022, then plunged 179744.44% in 2025.
- Valion Bio's Change in Inventory stood at $139000.0 in 2021, then dropped by 26.62% to $102000.0 in 2022, then slumped by 237.25% to -$140000.0 in 2023, then jumped by 106.43% to $9000.0 in 2024, then slumped by 179744.44% to -$16.2 million in 2025.
- Business Quant data shows VBIO's Change in Inventory at -$16.2 million in Q4 2025, -$49000.0 in Q3 2025, and -$23000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.17 Mn |
| Dec 31, 2025 | -16.17 Mn |
| Sep 30, 2025 | -49,000.00 |
| Sep 30, 2025 | -49,000.00 |
| Jun 30, 2025 | -23,000.00 |
| Jun 30, 2025 | -23,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Sep 30, 2023 | -60,000.00 |